Evidence map›Paper›PMID 20943792›Full record

ArticleThe American journal of clinical nutrition2010

Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes.

Chia-Chi Chuang, Kristina Martinez, Guoxiang Xie, Arion Kennedy, Akkarach Bumrungpert, Angel Overman, Wei Jia, Michael K McIntosh

Abstract read
In one paragraph

Article in The American journal of clinical nutrition, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 201 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Beneficial effects ofPharmaceutical biology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Neoteric Role of Quercetin in Visual Disorders.Current drug research reviews · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. Fishing the Targets of Bioactive Compounds fromInternational journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. Focus on the high therapeutic potentials of quercetin and its derivatives.Phytomedicine plus : international journal of phytotherapy and phytopharmacology · 2022
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chia-Chi ChuangDepartment of Nutrition, University of North Carolina-Greensboro, Greensboro, NC, USA.
Kristina Martinez
Guoxiang Xie
Arion Kennedy
Akkarach Bumrungpert
Angel Overman
Wei Jia
Michael K McIntosh
University of North Carolina at Greensboro · US

Funding

Conjugated linoleic acid (CLA) promotes inflammation in human adipocytesF31DK084812 · NIDDK · UNIVERSITY OF NORTH CAROLINA GREENSBORO · PI MARTINEZ-GURYN, KRISTINA BROOKE · 2009 to 2010
$57k
NIDDK NIH HHS F31 DK084812
6 · The paper itself

Abstract

backgroundQuercetin and trans-resveratrol (trans-RSV) are plant polyphenols reported to reduce inflammation or insulin resistance associated with obesity. Recently, we showed that grape powder extract, which contains quercetin and trans-RSV, attenuates markers of inflammation in human adipocytes and macrophages and insulin resistance in human adipocytes. However, we do not know how quercetin and trans-RSV individually affected these outcomes.

objectiveThe aim of this study was to examine the extent to which quercetin and trans-RSV prevented inflammation or insulin resistance in primary cultures of human adipocytes treated with tumor necrosis factor-α (TNF-α)-an inflammatory cytokine elevated in the plasma and adipose tissue of obese, diabetic individuals.

designCultures of human adipocytes were pretreated with quercetin and trans-RSV followed by treatment with TNF-α. Subsequently, gene and protein markers of inflammation and insulin resistance were measured.

resultsQuercetin, and to a lesser extent trans-RSV, attenuated the TNF-α-induced expression of inflammatory genes such as interleukin (IL)-6, IL-1β, IL-8, and monocyte chemoattractant protein-1 (MCP-1) and the secretion of IL-6, IL-8, and MCP-1. Quercetin attenuated TNF-α-mediated phosphorylation of extracellular signal-related kinase and c-Jun-NH₂ terminal kinase, whereas trans-RSV attenuated only c-Jun-NH₂ terminal kinase phosphorylation. Quercetin and trans-RSV attenuated TNF-α-mediated phosphorylation of c-Jun and degradation of inhibitory κB protein. Quercetin, but not trans-RSV, decreased TNF-α-induced nuclear factor-κB transcriptional activity. Quercetin and trans-RSV attenuated the TNF-α-mediated suppression of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγ target genes and of PPARγ protein concentrations and transcriptional activity. Quercetin prevented the TNF-α-mediated serine phosphorylation of insulin receptor substrate-1 and protein tyrosine phosphatase-1B gene expression and the suppression of insulin-stimulated glucose uptake, whereas trans-RSV prevented only the TNF-α-mediated serine phosphorylation of insulin receptor substrate-1.

conclusionThese data suggest that quercetin is equally or more effective than trans-RSV in attenuating TNF-α-mediated inflammation and insulin resistance in primary human adipocytes.

Indexed as

Insulin ResistanceAdipocytesAdultAnti-Inflammatory AgentsFemaleGene ExpressionGlucoseHumansInflammationInsulinMiddle AgedPhosphorylationPhytotherapyPlant ExtractsPPAR gammaQuercetinAnti-Inflammatory AgentsGlucoseInsulinPlant ExtractsPPAR gammaQuercetinResveratrolStilbenesTumor Necrosis Factor-alpha

Identifiers

PMID20943792
PMCPMC13189223
OpenAlexW2106010278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.